<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000631063">
  <TermName>zafirlukast</TermName>
  <TermPronunciation>(zuh-FER-loo-kast)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used to prevent and treat symptoms of asthma. It blocks substances that cause inflammation in the lungs. It is a type of antiasthmatic agent and a leukotriene receptor antagonist. Also called Accolate.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000722644" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;zafirlukast&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000722643" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;zafirlukast&quot;" language="es" id="_4"/>
  <SpanishTermName>zafirlukast</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa para prevenir y tratar los síntomas del asma. Bloquea las sustancias que hacen inflamar los pulmones. Es un tipo de antiasmático y un antagonista del receptor del leucotrieno.  También se llama Accolate.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2008-12-30</DateFirstPublished>
</GlossaryTerm>
